Dr. Ayscue is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Retired
Cary, NC 27519- Is this information wrong?
Summary
- Specialized in Pathology, Immunopathology, Hematopathology and Transfusion medicine. I left Pathology to do a Family Medicine Residency and worked in small emergency departments until I retired.
Education & Training
Vidant Medical Center/East Carolina UniversityResidency, Family Medicine, 2002 - 2005
University of North Carolina HospitalsFellowship, Blood Banking/Transfusion Medicine, 1996 - 1997- University of North Carolina HospitalsResidency, Immunopathology, 1994 - 1995
- University of North Carolina HospitalsResidency, Pathology-Anatomic and Clinical, 1989 - 1994
University of North Carolina at Chapel Hill School of MedicineClass of 1989
Certifications & Licensure
NC State Medical License 1994 - 2017- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Family MedicineFamily Medicine
Awards, Honors, & Recognition
- Phillip Blatt Teaching Award UNC Department of Pathology, 2002
- Graduated with Honors from UNC-CH Medical School UNC-CH Medical School, 1989
- AOA UNC-CH, 1988
Publications & Presentations
PubMed
- 32 citationsFollicular lymphoma with a burkitt translocation--predictor of an aggressive clinical course: a case report and review of the literature.Peter M. Voorhees, Kathryn A. Carder, Scott V. Smith, Lanier H. Ayscue, Kathleen W. Rao, Cherie H. Dunphy> ;Archives of Pathology & Laboratory Medicine. 2004 Feb 1
- 90 citationsRole of Estrogen Receptor in the Regulation of Ecto-5′-Nucleotidase and Adenosine in Breast CancerJozef Spychala, Eduardo Lazarowski, Anna Ostapkowicz, Lanier H. Ayscue, Aiwen Jin, Beverly S. Mitchell> ;Clinical Cancer Research. 2004 Jan 15
- 54 citationsInhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II geneJing Jin Gu, Sander Stegmann, Karen Gathy, Robert D. Murray, Josée Laliberté, Lanier H. Ayscue, Beverly S. Mitchell> ;The Journal of Clinical Investigation. 2000 Aug 15
- Join now to see all
Grant Support
- Regulation Of Deoxycytidine Kinase In Leukemic CellsNational Cancer Institute1994–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
